Analytical Data
-
Gene name
CCL24
- Application
-
Alternative Names
CCL24；MPIF2；；C-C motif chemokine 24
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O00175
-
Expression Region
27-104aa
-
AA Sequence
VVIPSPCCMF FVSKRIPENR VVSYQLSSRS TCLKAGVIFT TKKGQQFCGD PKQEWVQRYM KNLDAKQKKA SPRARAVA
-
Molecular Weight
8.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CCL24, also known as eotaxin-2, is a chemokine that plays a crucial role in the recruitment of eosinophils and other immune cells to sites of inflammation, particularly in allergic responses and asthma. Its importance in various physiological and pathological processes has attracted significant attention in the field of immunology and therapeutic development. Studies have shown that CCL24 is involved in tissue repair and remodeling, as well as in the pathogenesis of various diseases, including asthma, allergic rhinitis, and certain cancers. The recombinant protein form of CCL24 enables researchers to explore its biological functions, binding interactions with receptors, and potential therapeutic applications. By generating CCL24 through recombinant DNA technology, scientists can produce sufficient quantities for in-depth studies, facilitating investigations into its role in modulating immune responses and its potential as a target for drug development. Moreover, understanding the structural and functional properties of CCL24 may lead to innovative approaches to manipulate its activity, opening avenues for treatments that can mitigate inflammatory diseases and improve patient outcomes. Consequently, the research on CCL24 recombinant proteins not only advances our knowledge of chemokine biology but also holds promise for developing novel therapeutic strategies against various inflammatory conditions.
